Literature DB >> 3710429

Hemodynamic studies in long- and short-term portal hypertensive rats: the relation to systemic glucagon levels.

E Sikuler, R J Groszmann.   

Abstract

It is not known whether the hyperdynamic state which has been observed in several experimental models and in patients with portal hypertension reflects a temporary phase during the evolution of the portal hypertensive syndrome or is an expression of a permanent steady state. A hemodynamic study was performed in a group of rats with long-standing portal hypertension induced by portal vein constriction performed 6.2 +/- 0.1 months earlier. A group of rats matched by age and weight with short-term (20.7 +/- 0.9 days) portal hypertension and a group of long-term (6.2 +/- 0.1 months) sham-operated rats were used as controls. Cardiac output and regional blood flows were measured using a radioactive microsphere technique. Arterial blood levels of glucagon, a known vasodilator that was implicated in the etiology of the hyperdynamic circulation, were also measured. Portal pressure in long- and short-term portal hypertensive groups (12.3 +/- 0.4 and 13.7 +/- 0.4 mm Hg; not statistically significant) was higher than in the sham group (9.0 +/- 0.3 mm Hg; p less than 0.01). Cardiac output in the long-term portal hypertensive rats was similar to the sham-operated group and lower than in the short-term portal hypertensive group (19.4 +/- 1.0 and 20.6 +/- 1.5 vs. 32.7 +/- 2.0 ml X min-1 X 100 gm body weight-1; p less than 0.01). Portal venous inflow in the long-term portal hypertensive group was also similar to the sham group and lower than in the short-term portal hypertensive group (4.51 +/- 0.36 and 4.58 +/- 0.39 vs. 6.72 +/- 0.48 ml X min-1.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710429     DOI: 10.1002/hep.1840060315

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

Review 1.  Pathophysiology and epidemiology of portal hypertension.

Authors:  H Okumura; T Aramaki; Y Katsuta
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 2.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

3.  Evaluation of portal-systemic shunting in rats from mesenteric and splenic beds.

Authors:  R E Stauber; F W Ruthardt; W N Tauxe; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

4.  Increased plasma levels of corticosterone and prolactin and decreased T3 and T4 levels in short-term prehepatic portal hypertension in rats.

Authors:  G Monterde; G Rodríguez-Fabian; E Vara; L López; J Arias; M A Aller; J Arias
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

Review 5.  Management of hepatorenal syndrome in patients with cirrhosis.

Authors:  Vicente Arroyo; Javier Fernández
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

6.  Hepatic lipid metabolism changes in short- and long-term prehepatic portal hypertensive rats.

Authors:  Maria-Angeles Aller; Elena Vara; Cruz García; Maria-Paz Nava; Alejandra Angulo; Fernando Sánchez-Patán; Ana Calderón; Patri Vergara; Jaime Arias
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

7.  Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress.

Authors:  T J Johnson; E M Quigley; T E Adrian; G Jin; L F Rikkers
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Effect of portosystemic shunting on PGI2 and glucagon levels in humans.

Authors:  J V Sitzmann; K A Campbell; Y Wu; J L Cameron
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

9.  Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.

Authors:  J V Sitzmann; G B Bulkley; M C Mitchell; K Campbell
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

10.  Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels.

Authors:  J M Romeo; C Novo; A Fernández-Cruz; J M Lòpez-Novoa
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.